Making chemotherapy more effective
Professor Ahmed's lab is leading groundbreaking research to find ways of making paclitaxel chemotherapy more effective. Whilst many patients with ovarian cancer respond well to paclitaxel, about 60% do not. Overcoming such resistance to chemotherapy is a major challenge.
‘Apple shape’ more strongly linked to risk of heart attack in women
Women with bigger waists relative to their hips face a proportionately greater risk of experiencing a heart attack than men who have a similar ‘apple shape’, new research from The George Institute for Global Health, (Nuffield Department of Women's & Reproductive Health).
Read more
Opportunities for Pregnant Women
The Oxford Safer Pregnancy Alliance (OSPREA) facilitates the recruitment of pregnant women for a wide range of observational and interventional studies. These studies involve women who are not currently pregnant, to those in the first trimester of pregnancy and onward. We are primarily supported by the Nuffield Department of Women's & Reproductive Health, the Oxford University Hospitals NHS Foundation Trust and the Thames Valley CRN, part of the National Institute for Health Research.
Read moreCANCER
Learn about the genesis and formation of micrometastases in Ovarian Cancer and how they can develop resistance to chemotherapy.
Show moreGLOBAL HEALTH
Explore what can happen to mother and infant in the time before and after birth, such as infections, low birthweights and much more.
Show moreMATERNAL & FETAL HEALTH
Discover more about health and disease throughout pregnancy and the effects on maternal and fetal outcome in both the short and the long term.
Show moreREPRODUCTIVE MEDICINE & GENETICS
Read about infertility, pelvic pain, therapies for mitochondrial disease and improvement of assisted reproductive technologies (ART).
Show moreWHAT WE DO
The Nuffield Department of Women's & Reproductive Health encompasses multi-disciplinary research across the full spectrum of women’s health. Our work has four overarching themes; Cancer, Global Health, Maternal & Fetal Health and Reproductive Medicine & Genetics. We also teach students and provide clinical care for Oxford University Hospitals NHS Trust. The Department also includes The George Institute for Global Health (TGI) whose mission is to increase access to quality health care for millions of people worldwide - with a particular focus on vulnerable women in resource-poor settings.
Find out moreLatest news
-
Prof Terry Dwyer to step down as Executive Director
27 March 2018
-
Making chemotherapy more effective
12 March 2018
-
Healthy weight gain in pregnancy - your opinion needed
5 February 2018
-
Prof Jo Poulton: Research is in my DNA
1 February 2018
STUDY
We offer a world class MSc in Clinical Embryology. This one-year, residential, taught MSc course is based in purpose built premises at Winchester House within Oxford Science Park, with dedicated state of the art teaching and research facilities. It has won numerous University awards for teaching innovation and excellence.
We are currently closed for applications for entry in October 2018. If places are still available, we may reopen for applications on Tuesday 1st May 2018.
See course overviewSenior Department Staff
-
Stephen Kennedy
Head of Department & Professor of Reproductive Medicine
-
Lesa Levett
Head of Administration & Finance
-
Robyn Norton
Acting Executive Director, The George Institute, UK.
-
Krina Zondervan
Professor of Reproductive & Genomic Epidemiology, Co-Director Endometriosis CaRe centre, Director of Graduate Studies
CONTACT US
We are located across four Oxford sites: the Women's Centre, Weatherall Institute of Molecular Medicine, Winchester House and Le Gros Clark Building. See more
Looking for someone? View our team of researchers and research support staff, graduate research students and administrative staff here
Find out more